These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7100829)

  • 21. The effect of trimethoprim-sulphonamide, trimethoprim and sulphonamide on the occurrence of resistant enterobacteriaceae in human intestinal flora.
    Knothe H
    Infection; 1979; 7 Suppl 4():S321-3. PubMed ID: 389808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aminoglycoside resistance of enterobacteria isolated from urinary infections in surgical departments].
    Muntean D; Licker M; Berceanu-Văduva D; Crăciunescu M; Hogea E; Popa M; Adămut M; Rădulescu M; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):99-102. PubMed ID: 19856848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The distribution of the DHFR genes in trimethoprim-resistant urinary tract isolates from Taiwan.
    Chang LL; Chang SF; Chow TY; Wu WJ; Chang JC
    Epidemiol Infect; 1992 Dec; 109(3):453-62. PubMed ID: 1334841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cooperative controlled study of the use of trimethoprim-sulfamethoxazole in chronic urinary tract infections.
    Gleckman RA
    J Infect Dis; 1973 Nov; 128():Suppl:647-51 p. PubMed ID: 4585965
    [No Abstract]   [Full Text] [Related]  

  • 25. Trimethoprim-sulfamethoxazole in recurrent urinary tract infection in children.
    Forbes PA; Drummond KN
    J Infect Dis; 1973 Nov; 128():Suppl:626-8 p. PubMed ID: 4585961
    [No Abstract]   [Full Text] [Related]  

  • 26. Trimethoprim resistance in Finland after five years' use of plain trimethoprim.
    Huovinen P; Toivanen P
    Br Med J; 1980 Jan; 280(6207):72-4. PubMed ID: 7353129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimethoprim-resistant coliforms.
    Lacey RW; Bruten DM; Gillespie WA; Lewis EL
    Lancet; 1972 Feb; 1(7747):409-10. PubMed ID: 4110643
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanisms of trimethoprim resistance in enterobacteria isolated in Finland.
    Then RL; Hermann F
    Chemotherapy; 1981; 27(3):192-9. PubMed ID: 7226974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a slow-release trimethoprim with co-trimoxazole: efficacy and selection of resistance in the Enterobacteriaceae.
    Menon R; Roberts FE; Barr KW; Howard H; Lord VL; Hegarty MA; Luxton DE; Lacey RW
    J Antimicrob Chemother; 1986 Sep; 18(3):415-20. PubMed ID: 3533889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association.
    Pouwels KB; Freeman R; Muller-Pebody B; Rooney G; Henderson KL; Robotham JV; Smieszek T
    J Antimicrob Chemother; 2018 Jun; 73(6):1700-1707. PubMed ID: 29394363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trimethoprim resistance of Escherichia coli in outpatients in Finland after ten years' use of plain trimethoprim.
    Huovinen P; Renkonen OV; Pulkkinen L; Sunila R; Grönroos P; Klossner ML; Virtanen S; Toivanen P
    J Antimicrob Chemother; 1985 Oct; 16(4):435-41. PubMed ID: 2999058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
    Cahen P; Honderlick P
    Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar es Salaam, Tanzania.
    Manyahi J; Moyo SJ; Tellevik MG; Ndugulile F; Urassa W; Blomberg B; Langeland N
    BMC Infect Dis; 2017 Apr; 17(1):282. PubMed ID: 28415986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimicrobial resistance among uropathogens responsible for community-acquired urinary tract infections in an Italian community.
    Miragliotta G; Di Pierro MN; Miragliotta L; Mosca A
    J Chemother; 2008 Dec; 20(6):721-7. PubMed ID: 19129070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between rifampicin and trimethoprim in vitro and in experimental infections.
    Arioli V; Berti M; Carniti G; Rossi E
    J Antimicrob Chemother; 1977 Jan; 3(1):87-94. PubMed ID: 321415
    [No Abstract]   [Full Text] [Related]  

  • 37. Trimethoprim resistance in hospitals.
    Huovinen P; Mäntyjärvi R; Toivanen P
    Br Med J (Clin Res Ed); 1982 Mar; 284(6318):782-4. PubMed ID: 6802226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalent mechanisms of resistance among common enterobacterial isolates in Greek hospitals.
    Legakis NJ; Maniatis A; Tzouvelekis LS
    Microb Drug Resist; 1995; 1(4):331-3. PubMed ID: 9158805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections.
    Concia E; Bragantini D; Mazzaferri F
    J Chemother; 2017 Dec; 29(sup1):19-28. PubMed ID: 29271735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.